Reperfusion therapy for ST elevation acute myocardial
infarction 2010/2011: current status in 37 ESC countries

J 2014

Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries

KRISTENSEN, Steen D.; Kristina G. LAUT; Jean FAJADET; Zuzana KAIFOSZOVA; Petr KALA et al.

Základní údaje

Originální název

Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries

Autoři

KRISTENSEN, Steen D.; Kristina G. LAUT; Jean FAJADET; Zuzana KAIFOSZOVA; Petr KALA; Mario Di CARLO; William WIJNS; Peter CLEMMENSEN; Vaja AGLADZE; Loizos ANTONIADES; Khalid F. ALHABIB; Menko-Jan De BOER; MarcJ. CLAEYS; Dan DELEANU; Dariusz DUDEK; Andrejs ERGLIS; Martine GILARD; Omer GOKTEKIN; Giulio GUAGLIUMI; Thorarinn GUDNASON; Kim Wadt HANSEN; Kurt HUBER; Stefan JAMES; Tomáš JANOTA; Siobhan JENNINGS; Olli KAJANDER; John KANAKAKIS; Kiril K. KARAMFILOFF; Sasko KEDEV; Ran KORNOWSKI; Peter F. LUDMAN; Béla MERKELY; Davor MILICIC; Ruslan NAJAFOV; Francesca A. NICOLINI; Marko NOČ; Miodrag OSTOJIC; Hélder PEREIRA; Dragana RADOVANOVIC; Manel SABATÉ; Mohamed SOBHY; Maxim SOKOLOV; Martin STUDENCAN; Ibrahim TERZIC; Steffen WAHLER a Petr WIDIMSKY

Vydání

European heart journal, Oxford, Oxford University Press, 2014, 0195-668X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30201 Cardiac and Cardiovascular systems

Stát vydavatele

Velká Británie a Severní Irsko

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 15.203

Označené pro přenos do RIV

Ano

Kód RIV

RIV/00216224:14110/14:00075579

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Primary percutaneous coronary intervention; STEMI; Treatment variation; Europe

Štítky

EL OK

Příznaky

Mezinárodní význam, Recenzováno

Změněno: 23. 10. 2014 14:01, Soňa Böhmová

Anotace

V originále

Aims Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. Methods and results A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries. Conclusion Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged.

Citovat

@article{1183922,
   author = {Kristensen, Steen D. and Laut, Kristina G. and Fajadet, Jean and Kaifoszova, Zuzana and Kala, Petr and Carlo, Mario Di and Wijns, William and Clemmensen, Peter and Agladze, Vaja and Antoniades, Loizos and Alhabib, Khalid F. and Boer, MenkoandJan De and Claeys, MarcJ. and Deleanu, Dan and Dudek, Dariusz and Erglis, Andrejs and Gilard, Martine and Goktekin, Omer and Guagliumi, Giulio and Gudnason, Thorarinn and Hansen, Kim Wadt and Huber, Kurt and James, Stefan and Janota, Tomáš and Jennings, Siobhan and Kajander, Olli and Kanakakis, John and Karamfiloff, Kiril K. and Kedev, Sasko and Kornowski, Ran and Ludman, Peter F. and Merkely, Béla and Milicic, Davor and Najafov, Ruslan and Nicolini, Francesca A. and Noč, Marko and Ostojic, Miodrag and Pereira, Hélder and Radovanovic, Dragana and Sabaté, Manel and Sobhy, Mohamed and Sokolov, Maxim and Studencan, Martin and Terzic, Ibrahim and Wahler, Steffen and Widimsky, Petr},
   article_location = {Oxford},
   article_number = {29},
   doi = {https://doi.org/10.1093/eurheartj/eht529},
   keywords = {Primary percutaneous coronary intervention; STEMI; Treatment variation; Europe},
   language = {eng},
   issn = {0195-668X},
   journal = {European heart journal},
   title = {Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries},
   volume = {35},
   year = {2014}
}

TY  - JOUR
ID  - 1183922
AU  - Kristensen, Steen D. - Laut, Kristina G. - Fajadet, Jean - Kaifoszova, Zuzana - Kala, Petr - Carlo, Mario Di - Wijns, William - Clemmensen, Peter - Agladze, Vaja - Antoniades, Loizos - Alhabib, Khalid F. - Boer, Menko-Jan De - Claeys, MarcJ. - Deleanu, Dan - Dudek, Dariusz - Erglis, Andrejs - Gilard, Martine - Goktekin, Omer - Guagliumi, Giulio - Gudnason, Thorarinn - Hansen, Kim Wadt - Huber, Kurt - James, Stefan - Janota, Tomáš - Jennings, Siobhan - Kajander, Olli - Kanakakis, John - Karamfiloff, Kiril K. - Kedev, Sasko - Kornowski, Ran - Ludman, Peter F. - Merkely, Béla - Milicic, Davor - Najafov, Ruslan - Nicolini, Francesca A. - Noč, Marko - Ostojic, Miodrag - Pereira, Hélder - Radovanovic, Dragana - Sabaté, Manel - Sobhy, Mohamed - Sokolov, Maxim - Studencan, Martin - Terzic, Ibrahim - Wahler, Steffen - Widimsky, Petr
PY  - 2014
TI  - Reperfusion therapy for ST elevation acute myocardial infarction 2010/2011: current status in 37 ESC countries
JF  - European heart journal
VL  - 35
IS  - 29
SP  - 1957-1970
EP  - 1957-1970
PB  - Oxford University Press
SN  - 0195668X
KW  - Primary percutaneous coronary intervention
KW  - STEMI
KW  - Treatment variation
KW  - Europe
N2  - Aims Primary percutaneous coronary intervention (PPCI) is the preferred reperfusion therapy in ST-elevation myocardial infarction (STEMI). We conducted this study to evaluate the contemporary status on the use and type of reperfusion therapy in patients admitted with STEMI in the European Society of Cardiology (ESC) member countries. Methods and results A cross-sectional descriptive study based on aggregated country-level data on the use of reperfusion therapy in patients admitted with STEMI during 2010 or 2011. Thirty-seven ESC countries were able to provide data from existing national or regional registries. In countries where no such registries exist, data were based on best expert estimates. Data were collected on the use of STEMI reperfusion treatment and mortality, the numbers of cardiologists, and the availability of PPCI facilities in each country. Our survey provides a brief data summary of the degree of variation in reperfusion therapy across Europe. The number of PPCI procedures varied between countries, ranging from 23 to 884 per million inhabitants. Primary percutaneous coronary intervention and thrombolysis were the dominant reperfusion strategy in 33 and 4 countries, respectively. The mean population served by a single PPCI centre with a 24-h service 7 days a week ranged from 31 300 inhabitants per centre to 6 533 000 inhabitants per centre. Twenty-seven of the total 37 countries participated in a former survey from 2007, and major increases in PPCI utilization were observed in 13 of these countries. Conclusion Large variations in reperfusion treatment are still present across Europe. Countries in Eastern and Southern Europe reported that a substantial number of STEMI patients are not receiving any reperfusion therapy. Implementation of the best reperfusion therapy as recommended in the guidelines should be encouraged.
ER  -

Přehled o publikaci